AC Immune SA Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio8.8628.1137.0322.75
P/B Ratio2.162.590.861.821.63
Price/Tangible Book3.913.771.232.331.63
Price/FCF3.71
Price/OCF3.68
Enterprise Value Ratios
EV/Revenue2.7823.283.997.48
EV/FCF1.16
Profitability & Returns
Return on Equity (ROE)-0.37%-0.33%-0.35%-0.33%-0.25%
Return on Assets (ROA)-0.16%-0.18%-0.20%-0.20%-0.14%
Return on Capital Employed (ROCE)-0.40%-0.32%-0.41%-0.33%-0.27%
Leverage & Solvency Ratios
Debt/Equity0.050.020.020.010.01
Debt/FCF0.08
Liquidity Ratios
Current Ratio1.719.2211.1610.1216.53
Quick Ratio1.668.7210.749.9716.25
Efficiency Ratios
Asset Turnover0.130.080.020.06
Yield & Distribution Ratios
Earnings Yield-0.21%-0.13%-0.49%-0.17%-0.18%
FCF Yield0.27%-0.15%-0.51%-0.16%-0.17%
Buyback Yield-0.18%-0.01%-0.11%-0.04%-0.01%